The Big Business Behind Weight Loss Drugs

More people are using fertility treatments to have kids later. But how much time can science really buy? Sanjay talks with reproductive endocrinologist Dr. Lucky Sekhon about what science can — and can’t — promise. Jennifer Lai and Leying Tang produced this episode. Video product ...  Show more

Antidepressants are some of the most prescribed drugs in the US, but they may not be getting proper scrutiny. Dr. Sanjay Gupta talks to psychopharmacologist Dr. Joseph Goldberg about what to consider when stopping or starting one. Madeleine Thompson & Sofia Sanchez produced this ...  Show more

Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ...  Show more

$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss: - How weight-loss drugs actually work, and how big- ...  Show more

You may have heard about Ozempic, Wegovy and Mounjaro. It’s tough to miss the online chatter, the ads on TV and all the news coverage. They are part of a class of drugs originally designed to treat diabetes, and all three have been shown to help people lose significant amounts of ...  Show more

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more